Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 1;36(1):38-46.
doi: 10.46497/ArchRheumatol.2021.7736. eCollection 2021 Mar.

Is there any association between low level of serum nesfatin-1 and fibromyalgia syndrome?

Birşen Bilgici  1 , Yeşim Akyol  2 , Yasemin Ulus  2 , Sebati Sinan Ürkmez  1 , Ömer Kuru  2
Affiliations

Is there any association between low level of serum nesfatin-1 and fibromyalgia syndrome?

Birşen Bilgici et al. Arch Rheumatol. .

Abstract

Objectives: This study aims to investigate the relationship between serum level of nesfatin-1 and fibromyalgia syndrome (FMS) clinical parameters such as pain severity, disease activity, fatigue, emotional state, and sleep quality.

Patients and methods: Forty-six female patients with FMS (median age 40 years; range, 18 to 53 years) and 46 healthy female controls (median age 36 years; range, 19 to 52 years) were included in the study. Severity of pain, disease activity, fatigue, sleep quality, and emotional status were evaluated by visual analog scale, Fibromyalgia Impact Questionnaire, Multidimensional Assessment of Fatigue (MAF), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI), respectively. Serum nesfatin-1 concentrations (pg/mL) were measured by enzyme-linked immunosorbent assay method.

Results: There was no significant difference with respect to demographic characteristics between the FMS patients and healthy controls. When clinical parameters were compared, MAF, BDI, BAI, and PSQI scores were significantly higher in FMS patients than controls (p<0.05). Serum nesfatin-1 concentration was significantly lower in patients with FMS (p<0.05). When compared to the FMS patients without anxiety, serum nesfatin-1 concentration was significantly increased in FMS patients with anxiety (p<0.05). Serum nesfatin-1 concentration was positively correlated with BAI scores in patients with FMS (p<0.05).

Conclusion: Low nesfatin-1 serum levels may contribute to pathological changes in FMS. In addition, nesfatin-1 may also be involved in the mediation of anxiety-related responses in FMS.

Keywords: Anxiety; fibromyalgia syndrome; nesfatin-1.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Similar articles

See all similar articles

Cited by

References

    1. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2010;39:448–453. - PubMed
    1. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61:1498–1508. - PMC - PubMed
    1. Talotta R, Bazzichi L, Di Franco M, Casale R, Batticciotto A, Gerardi MC, et al. One year in review 2017: fibromyalgia. Clin Exp Rheumatol. 2017;35:6–12. - PubMed
    1. Clauw DJ. Fibromyalgia: an overview. S3-S13Am J Med. 2009;122 - PubMed
    1. Alves B, Zakka TM, Teixeira MJ, Kaziyama HH, Siqueira JT, Siqueira SR. Depression, sexuality and fibromyalgia syndrome: clinical findings and correlation to hematological parameters. Arq Neuropsiquiatr. 2016;74:863–868. - PubMed

LinkOut - more resources